Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: A phase II trial

Harnsberger, 1994, Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer, Dis Colon Rectum, 37, 73, 10.1007/BF02047218 Kapiteijn, 1998, Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands, Eur J Surg Oncol, 24, 528, 10.1016/S0748-7983(98)93500-4 Havenga, 1999, Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients, Eur J Surg Oncol, 25, 368, 10.1053/ejso.1999.0659 Heald, 1998, Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997, Arch Surg, 133, 894, 10.1001/archsurg.133.8.894 Kapiteijn, 2002, Cooperative investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands, Br J Surg, 89, 1142, 10.1046/j.1365-2168.2002.02196.x Peeters, 2007, The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma, Ann Surg, 246, 693, 10.1097/01.sla.0000257358.56863.ce Bosset, 2006, Chemotherapy with preoperative radiotherapy in rectal cancer, N Engl J Med, 355, 1114, 10.1056/NEJMoa060829 Gérard, 2006, Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203, J Clin Oncol, 24, 4620, 10.1200/JCO.2006.06.7629 Capirci, 2008, Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients, Int J Radiat Oncol Biol Phys, 72, 99, 10.1016/j.ijrobp.2007.12.019 Saif, 2008, Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review, Int J Colorectal Dis, 23, 139, 10.1007/s00384-007-0382-z Kim, 2007, Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer, Int J Radiat Oncol Biol Phys, 67, 378, 10.1016/j.ijrobp.2006.08.063 Velenik, 2010, Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer, Radiat Oncol, 5, 88, 10.1186/1748-717X-5-88 Ballonoff, 2008, Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial, Am J Clin Oncol, 31, 264, 10.1097/COC.0b013e318161dbd3 Roels, 2006, Definition and delineation of the clinical target volume for rectal cancer, Int J Radiat Oncol Biol Phys, 65, 1129, 10.1016/j.ijrobp.2006.02.050 Gallagher, 1986, A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation, Int J Radiat Oncol Biol Phys, 12, 1565, 10.1016/0360-3016(86)90279-8 Baglan, 2002, The dose–volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer, Int J Radiat Oncol Biol Phys, 52, 176, 10.1016/S0360-3016(01)01820-X Dworak, 1997, Pathological features of rectal cancer after preoperative radiochemotherapy, Int J Colorectal Dis, 12, 19, 10.1007/s003840050072 Rödel, 2005, Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer, J Clin Oncol, 23, 8688, 10.1200/JCO.2005.02.1329 A’Hern, 2001, Sample size tables for exact single-stage phase II designs, Stat Med, 20, 859, 10.1002/sim.721 Fleming, 1982, One-sample multiple testing procedure for phase II clinical trials, Biometrics, 38, 143, 10.2307/2530297 Valentini, 2008, Evidence and research in rectal cancer, Radiother Oncol, 87, 449, 10.1016/j.radonc.2008.05.022 Freedman, 2007, Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer, Int J Radiat Oncol Biol Phys, 67, 1389, 10.1016/j.ijrobp.2006.11.017 Aschele, 2009, Preoperative fluorouracil (FU)-based chemoradiation with, without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial, J Clin Oncol, 27, 170s, 10.1200/jco.2009.27.18_suppl.cra4008 Rödel, 2003, Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer, J Clin Oncol, 21, 3098, 10.1200/JCO.2003.02.505 Gérard, 2010, Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2, J Clin Oncol, 28, 1638, 10.1200/JCO.2009.25.8376 Chua, 2010, Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial, Lancet Oncol, 11, 241, 10.1016/S1470-2045(09)70381-X Fowler, 1989, The linear-quadratic formula and progress in fractionated radiotherapy, Br J Radiol, 62, 679, 10.1259/0007-1285-62-740-679 Jones, 1999, Mathematical models of tumour and normal tissue response, Acta Oncol, 38, 883, 10.1080/028418699432572 Coucke, 2006, Preoperative hyper-fractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trial, Radiother Oncol, 79, 52, 10.1016/j.radonc.2006.02.004 Bujko, 2004, Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy, Radiother Oncol, 72, 15, 10.1016/j.radonc.2003.12.006 Gerard, 2005, The Estro Regaud Lecture. Radiotherapy in the conservative treatment of rectal cancer. Evidence-based medicine and opinion, Radiother Oncol, 74, 227, 10.1016/j.radonc.2004.11.005 De Paoli, 2006, Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study, Ann Oncol, 17, 246, 10.1093/annonc/mdj041 Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694 Debucquoy, 2009, Double blind randomized phase II study with radiation+5-fluorouracil±celecoxib for resectable rectal cancer, Radiother Oncol, 93, 273, 10.1016/j.radonc.2009.08.006